Cell and Gene Therapy

Overview

Cell and gene therapies are advanced modalities requiring entirely new manufacturing paradigms. There are 2,100 clinical trials for cell and gene therapies underway, but the ability to manufacture them reliably, at cost, and at scale is not keeping pace with the science. Cell and gene therapies require entirely new manufacturing paradigms, contributing to longer development timelines, higher cost of goods, and constrained patient access.